Copyright
©The Author(s) 2020.
World J Clin Cases. May 6, 2020; 8(9): 1735-1744
Published online May 6, 2020. doi: 10.12998/wjcc.v8.i9.1735
Published online May 6, 2020. doi: 10.12998/wjcc.v8.i9.1735
Ref. | Age | Clinical presentation | Surgery | Stage | Adjuvant therapy | Site, recurrence time, and treatment | Outcome |
McGee et al[27], 1962 | 38 | Postcoital vaginal bleeding | Uter | IB | No | Pelvis, 6 yr, NFT | DOD: 7 yr |
Buntine[28], 1979 | 48 | “Fibroids” | Uter + BAR | ? | No | Vagina, 7 yr, RT | DOD: 9 yr |
Valente et al[29], 1987 | 58 | Postmenopausal vaginal bleeding | RAU + BAR + LE | IB | No | Pelvis and sacrum, 2 yr, RT | DOD: 2 yr 10 mo |
Lang et al[30], 1990 | 46 | Cervical polyp | Uter | ? | RT | NA | DFS: 10 mo |
55 | None | Uter | IB | ? | ? | ? | |
Ferry et al[2], 1990 | 55 | Pelvic relaxation | Uter + BAR | / | RT | / | DFS: 5 yr |
Stewart et al[31], 1993 | 37 | Menometro-rrhagia | RAU + BAR + LE | IB1 | No | NA | DFS: 10 yr |
Clement et al[3], 1995 | 46 | Menorrhagia, “fibroid uterus” | Uter + BAR + LE | IB | ? | NA | DFS: 2 yr |
34 | Menometro-rrhagia | Uter + BAR + LE | IB | ? | Abdomen, 1 yr, CT | DFS: 2 yr | |
71 | AC on Pap smear, pelvic mass | Uter + BAR + LE | IB | RT | Abdomen, 4.5 mo, CT | DOD: 8.5 mo | |
67 | Vaginal bleeding, cervical mass, enlarged uterus | Uter + BAR + LE | IB | ? | ? | ? | |
37 | Postcoital bleeding | Uter + BAR + LE | IB | CT | Abdomen, 9 and 11 yr, chemotherapy | LWD: 13 yr | |
73 | Vaginal bleeding | Uter + BAR | IB | RT | NA | DFS: 3 yr | |
40 | Menorrhagia, cervical polyp | Uter + BAR | IB | RT | NA | DFS: 2.3 yr | |
39 | Menorrhagia, cervical “fibroid” | Uter + BAR | IB | No | ? | ? | |
Silver et al[24], 2001 | 62 | Postmenopausal bleeding | Uter + UAR | IB | No | NA | DFS: 1.5 yr |
47 | Uterine prolapse | Uter + BAR | IB | No | NA | DFS: 2.1 yr | |
40 | SIL (squamous intraepithelial lesion) on Pap smear | Uter + BAR | IB | No | NA | DFS: 3.2 yr | |
54 | Postmenopausal bleeding | Uter + BAR + LE | IB | No | NA | DFS: 6.1 yr | |
67 | Postmenopausal bleeding | Uter + BAR | IB | No | NA | DFS: 8.3 yr | |
72 | Atypical glandular cells on Pap smear | Uter + BAR + LE | IB | RT | Rectovaginal septum, 1.7 yr, CT | DFS: 2.5 yr | |
39 | Menorrhagia, cervical “fibroid” | Uter + BAR | IB | RT | Mediastinal metastasis and malignant pleural effusion, 5.6 yr, CT | DOD: 6.2 yr | |
62 | Postmenopausal bleeding | Uter + BAR + LE | IB | No | ? | ? | |
56 | Right ovarian cystadenoma | Uter + BAR | ? | No | NA | DFS: 7.4 yr | |
35 | Vaginal bleeding, pelvic pain | Biopsy of cervicovaginal mass | IIB | RT | Pelvis, 2.2 yr, CT | DOD: 3.2 yr | |
43 | Metrorrhagia, anemia | Uter + BAR + LE + OE | IVB | CT | Bladder and pelvis, 8 mo, RT | DOD: 10 mo | |
Angeles et al[32], 2004 | 47 | Menometro-rrhagia, pelvic pain | Uter + BAR | IIA | RT | NA | DFS: 1 yr |
Bagué et al[25], 2004 | 41 | Abnormal vaginal bleeding | Uter + BAR + LE + AE | IB | RT | NA | DFS: 11.4 yr |
24 | ? | ? | IIA | ? | ? | ? | |
45 | Postcoitum methrorragia | Uter + UAR | IB | NO | NA | DFS: 3.1 yr | |
54 | Vaginal bleeding | Uter + BAR + LE + OE | IIA | No | Bowel obstruction | DOD: 7 mo | |
62 | ? | Uter + BAR | IVB | CRT | Bone | LWD: 3.3 yr | |
54 | ? | Uter + BAR + LE + OE | IB1 | No | NA | DFS: 13 mo | |
Yap et al[16], 2006 | 54 | Postmenopausal vaginal bleeding | Uter + BAR + LE + AE | IB1 | RT | NA | DFS: 3.1 yr |
Fukunaga et al[33], 2008 | 46 | Abnormal vaginal bleeding | Uter + BAR + LE + OE | IB | NO | NA | DFS: 4 mo |
Anagno-stopoulos et al[5], 2012 | 64 | Asymptomatic | RAU + BAR + LE | IB1 | NO | NA | DFS: 6 mo |
Nomoto et al[34], 2012 | 64 | Postmenopausal vaginal bleeding | Uter + BAR + LE | IB2 | No | Multifocal lung metastases, 1 yr, CT | ? |
64 | Postmenopausal vaginal bleeding | Uter + BAR + LE | IB1 | No | NA | ? | |
Abdul-Ghafar et al[35], 2013 | 48 | Uterine mass | Vaginal uter | IB1 | CRT | NA | DFS: 2 yr |
Meguro et al[36], 2013 | 63 | Postmenopausal vaginal bleeding | RAU + BAR + LE | IIA | No | Local R (7 mo), CRT | DFS: 7 mo |
Menon et al[13], 2013 | 65 | Postmenopausal bleeding | Uter + BAR + LE | IB1 | RT | NA | DFS: 6 mo |
Roma[37], 2014 | 65 | Postmenopausal bleeding | Uter + BAR | IB1 | CT | Recent case | Recent case |
Dierickx et al[4], 2016 | 66 | Postmenopausal vaginal bleeding | CRT + Uter + BAR + LE | IIB | No | NA | DFS: 2 yr |
Kır et al[38], 2016 | 53 | ? | RAU + BAR + LE + AE | IB | ? | ? | ? |
Yeo et al[39], 2016 | 55 | Metastatic pulmonary nodules | ? | IV | ? | ? | ? |
Cavalcanti et al[18], 2017 | 59 | Postmenopausal bleeding | RAU + BAR + LE | IB1 | ? | Pelvic, 3 mo, CRT | DOD: 14 mo |
Papoutsis et al[40], 2019 | 67 | Postmenopausal bleeding | RAU + BAR + LE | IIB | CRT | NA | DFS: 12 mo |
Present case | 48 | Asymptomatic | Uter + BAR + LE + OE + AE | IV | CT | Lung, 2.8 yr, CT + targeted therapy | DFS: 2.8 yr; LWD: 2 yr |
- Citation: Jiang LL, Tong DM, Feng ZY, Liu KR. Mesonephric adenocarcinoma of the uterine cervix with rare lung metastases: A case report and review of the literature. World J Clin Cases 2020; 8(9): 1735-1744
- URL: https://www.wjgnet.com/2307-8960/full/v8/i9/1735.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i9.1735